Silynxcom (SYNX) VP details two share-option grants in Form 3 filing

Rhea-AI Filing Summary

Silynxcom Ltd. executive Cohen Elihay, the VP of Marketing & ISO, reports direct holdings of two share-option grants. One option covers 287,048 ordinary shares at an exercise price of $2.7900 per share, exercisable from January 1, 2023 and expiring on January 1, 2028, and was fully vested as of January 1, 2026. The second option covers 252,942 ordinary shares at an exercise price of $1.2700 per share, exercisable from January 1, 2023, fully vested as of December 31, 2023, and expiring on January 1, 2031.

Insider Trade Summary

2 transactions reported

Mixed 2 txns

Insider Cohen Elihay

Role VP of Mktg & ISO

Type	Security	Shares	Price	Value
holding	Share options (right to buy)	--	--	--
holding	Share options (right to buy)	--	--	--

Holdings After Transaction: Share options (right to buy) — 287,048 shares (Direct)

Footnotes (1)

1. The options were granted on January 1, 2023 and became fully vested as of January 1, 2026. The options were granted on January 1, 2023 and became fully vested as of December 31, 2023.

Understanding Insider Trading Forms →

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Cohen Elihay

(Last) (First) (Middle)

7 GIBOREI ISRAEL

(Street)

NETANYA 4250407

(City) (State) (Zip)

ISRAEL

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026

3. Issuer Name and Ticker or Trading Symbol
Silynxcom Ltd. [ SYNX ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	VP of Mktg & ISO

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Share options (right to buy)(1)	01/01/2023	01/01/2028	Ordinary Shares, no par value per share	287,048	$2.79	D
Share options (right to buy)(2)	01/01/2023	01/01/2031	Ordinary Shares, no par value per share	252,942	$1.27	D

Explanation of Responses:

1. The options were granted on January 1, 2023 and became fully vested as of January 1, 2026.

2. The options were granted on January 1, 2023 and became fully vested as of December 31, 2023.

	/s/ Elihay Cohen	03/19/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

FAQ

What does the Silynxcom (SYNX) Form 3 filing report for Cohen Elihay?

The Form 3 shows VP of Marketing & ISO Cohen Elihay directly holding two share-option grants over Silynxcom ordinary shares. It discloses exercise prices, vesting completion dates, and expiration dates, giving a clear view of his equity-based compensation position.

How many Silynxcom (SYNX) shares are covered by Cohen Elihay’s options?

One option grant covers 287,048 ordinary shares and another covers 252,942 ordinary shares. Both are structured as share options with rights to buy Silynxcom ordinary shares upon exercise at their respective fixed exercise prices.

What are the exercise prices of Cohen Elihay’s Silynxcom (SYNX) options?

Cohen Elihay holds one option grant with an exercise price of $2.7900 per ordinary share and another with an exercise price of $1.2700 per share. These fixed prices determine what he must pay if he chooses to exercise the options.

When do Cohen Elihay’s Silynxcom (SYNX) options vest and expire?

One option grant became fully vested as of January 1, 2026 and expires on January 1, 2028. The other became fully vested as of December 31, 2023 and expires on January 1, 2031, defining his future exercise window.

Are Cohen Elihay’s Silynxcom (SYNX) options currently exercisable?

Yes. Footnotes state both option grants were granted on January 1, 2023 and are fully vested by late 2023 or early 2026. Fully vested options are generally exercisable during their stated term until their respective expiration dates.